Diagnostyka S.A. (WSE:DIA)
147.50
+1.40 (0.96%)
Last updated: Nov 3, 2026, 4:49 PM CET
Diagnostyka Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Diagnostyka stock has a consensus rating of "Buy" and an average price target of zł 191.39. The average 1-year stock price forecast is 29.76% higher than the current stock price, while the lowest is zł 170.00 (+15.25%) and the highest is zł 215.00 (+45.76%).
Price Target: zł 191.39 (+29.76%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Jul 13, 2026.
Analyst Ratings
The average analyst rating for Diagnostyka stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 3 | 4 | 3 |
| Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold Maintains zł 188.00 → zł 176.00 | Hold | Maintains | zł 188.00 → zł 176.00 | +19.32% | Jul 13, 2026 |
Financial Forecast
Revenue This Year
2.75B
from 2.41B
Increased by 14.00%
Revenue Next Year
3.06B
from 2.75B
Increased by 11.31%
EPS This Year
7.61
from 7.50
Increased by 1.59%
EPS Next Year
9.74
from 7.61
Increased by 27.90%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is PLN.